SUZANNE HESS: Open Payments
NPI 1013054436 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 15 payments from 5 companies in 2025. Trend: 2023 $221 · 2024 $245 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $76 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Novo Nordisk Inc | 4 | $70 |
| Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, SHINGRIX, Wegovy, APLENZIN, MOUNJARO, Ozempic.
Industry payments across NJ — which companies pay providers there.
